Correlation Between Trustcash Holdings and Entrada Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Trustcash Holdings and Entrada Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Trustcash Holdings and Entrada Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Trustcash Holdings and Entrada Therapeutics, you can compare the effects of market volatilities on Trustcash Holdings and Entrada Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Trustcash Holdings with a short position of Entrada Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Trustcash Holdings and Entrada Therapeutics.

Diversification Opportunities for Trustcash Holdings and Entrada Therapeutics

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Trustcash and Entrada is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Trustcash Holdings and Entrada Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entrada Therapeutics and Trustcash Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Trustcash Holdings are associated (or correlated) with Entrada Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entrada Therapeutics has no effect on the direction of Trustcash Holdings i.e., Trustcash Holdings and Entrada Therapeutics go up and down completely randomly.

Pair Corralation between Trustcash Holdings and Entrada Therapeutics

Given the investment horizon of 90 days Trustcash Holdings is expected to under-perform the Entrada Therapeutics. In addition to that, Trustcash Holdings is 8.55 times more volatile than Entrada Therapeutics. It trades about -0.22 of its total potential returns per unit of risk. Entrada Therapeutics is currently generating about 0.28 per unit of volatility. If you would invest  1,714  in Entrada Therapeutics on September 1, 2024 and sell it today you would earn a total of  275.00  from holding Entrada Therapeutics or generate 16.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.24%
ValuesDaily Returns

Trustcash Holdings  vs.  Entrada Therapeutics

 Performance 
       Timeline  
Trustcash Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Trustcash Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's technical indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Entrada Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Entrada Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating fundamental indicators, Entrada Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Trustcash Holdings and Entrada Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Trustcash Holdings and Entrada Therapeutics

The main advantage of trading using opposite Trustcash Holdings and Entrada Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Trustcash Holdings position performs unexpectedly, Entrada Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entrada Therapeutics will offset losses from the drop in Entrada Therapeutics' long position.
The idea behind Trustcash Holdings and Entrada Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Money Managers
Screen money managers from public funds and ETFs managed around the world